Lauren Sciences LLC awarded third grant for LAUR-301 from The ALS Association

(Lauren Sciences LLC) Lauren Sciences LLC, the private New York biotechnology company developing transformative V-Smart® Nanomedicines for brain diseases, today announced the award of its third grant from The ALS Association. The ALS Association grant will support Lauren Sciences continued development of LAUR-301, its novel V-Smart® Nanomedicine for ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease. Future success of LAUR-301 is expected to provide an effective new treatm...